$ICPT Another body for the NASH grave yard. Later stage liver injury F3-F4 is notorious because it is multifactorial. FDA probably didn't like their general approach. Overall death, what a joke. Need some biomarker or objective measure like MRI, fat reduction. And then, hope that proves some clinical benefit. Sorry for LT holders, there is still some value here but sheesh.